| Rachele J Lyons, CNP | |
|
405 Whittecar Ave, Gregory, SD 57533-1340 | |
| (605) 835-9611 | |
| (605) 835-8033 |
| Full Name | Rachele J Lyons |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 405 Whittecar Ave, Gregory, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982084521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP000954 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera Gregory Hospital | Gregory, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
News Archive
Persons in their late middle age are not too late to work on their exercise routines to improve their heart health, finds a new study. Two years of aerobic exercises, at least four to five days a week can reverse the damage caused by years of sedentary non-active life before and also reduce the risk of heart failure. The study was published in the latest issue of the journal Circulation.
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi (ruxolitinib) for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
Early on in the COVID-19 pandemic, health officials seized on contact tracing as the most effective way to anticipate the virus's migration from the initial, densely populated hot spots and try to curb its spread.
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
› Verified 1 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
Persons in their late middle age are not too late to work on their exercise routines to improve their heart health, finds a new study. Two years of aerobic exercises, at least four to five days a week can reverse the damage caused by years of sedentary non-active life before and also reduce the risk of heart failure. The study was published in the latest issue of the journal Circulation.
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi (ruxolitinib) for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
Early on in the COVID-19 pandemic, health officials seized on contact tracing as the most effective way to anticipate the virus's migration from the initial, densely populated hot spots and try to curb its spread.
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachele J Lyons, CNP 405 Whittecar Ave, Gregory, SD 57533-1340 Ph: (605) 835-9611 | Rachele J Lyons, CNP 405 Whittecar Ave, Gregory, SD 57533-1340 Ph: (605) 835-9611 |
News Archive
Persons in their late middle age are not too late to work on their exercise routines to improve their heart health, finds a new study. Two years of aerobic exercises, at least four to five days a week can reverse the damage caused by years of sedentary non-active life before and also reduce the risk of heart failure. The study was published in the latest issue of the journal Circulation.
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi (ruxolitinib) for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
Early on in the COVID-19 pandemic, health officials seized on contact tracing as the most effective way to anticipate the virus's migration from the initial, densely populated hot spots and try to curb its spread.
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
› Verified 1 days ago
Mrs. Erin A Tobin, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 405 Whittecar Ave, Gregory, SD 57533 Phone: 605-835-9611 Fax: 605-835-8033 | |
Susan M Hogue, C.N.P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 405 Whittecar Ave, Gregory, SD 57533 Phone: 605-835-9611 Fax: 605-835-8033 | |
Mrs. Megan Jo Heyden, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 405 Whittecar Ave, Gregory, SD 57533 Phone: 605-835-9611 |